Δ9-tetrahydrocannabinol

Δ9-tetrahydrocannabinol Brand names, Δ9-tetrahydrocannabinol Analogs

Δ9-tetrahydrocannabinol Brand Names Mixture

No information avaliable

Δ9-tetrahydrocannabinol Chemical_Formula

C₂₁H₃₀O₂

Δ9-tetrahydrocannabinol RX_link

http://www.rxlist.com/cgi/generic2/drona.htm

Δ9-tetrahydrocannabinol fda sheet

Δ9-tetrahydrocannabinol FDA

Δ9-tetrahydrocannabinol msds (material safety sheet)

Δ9-tetrahydrocannabinol MSDS

Δ9-tetrahydrocannabinol Synthesis Reference

No information avaliable

Δ9-tetrahydrocannabinol Molecular Weight

314.462 g/mol

Δ9-tetrahydrocannabinol Melting Point

200 ^oC at 2.00E-02 mm Hg

Δ9-tetrahydrocannabinol H₂O Solubility

2.8 mg/ml

Δ9-tetrahydrocannabinol State

Solid

Δ9-tetrahydrocannabinol LogP

5.648

Δ9-tetrahydrocannabinol Dosage Forms

Capsule

Δ9-tetrahydrocannabinol Indication

For the treatment of anorexia associated with weight loss in patients with AIDS, and nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments

Δ9-tetrahydrocannabinol Pharmacology

Dronabinol may has complex effects on the central nervous system (CNS), including cannabinoid receptors. Dronabinol may inhibit endorphins in the emetic center, suppress prostaglandin synthesis, and/or inhibit medullary activity through an unspecified cortical action.

Δ9-tetrahydrocannabinol Absorption

90 - 95%

Δ9-tetrahydrocannabinol side effects and Toxicity